{"disease":{"id":"positron-emission-tomography","name":"Positron emission tomography","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":15,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"gallium-68ga-edotreotide","indication_name":"Positron emission tomography with computed tomography of whole body using gallium (68-Ga) dotatate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ga 68 Dotatate","generic_name":"gallium (68Ga) edotreotide","company_name":"Uihc Pet Imaging","drug_phase":"marketed","molecular_target":"Somatostatin receptor type 2","drug_class":"","quality_score":32,"revenue":"305","mechanism":""},{"drug_id":"flotufolastat-f-18-gallium","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Posluma","generic_name":"FLOTUFOLASTAT F-18 GALLIUM","company_name":"Blue Earth","drug_phase":"marketed","molecular_target":"Glutamate carboxypeptidase 2","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":45,"revenue":null,"mechanism":"Posluma works by binding to glutamate carboxypeptidase 2, a protein found in certain types of cancer cells."},{"drug_id":"florbetapir-f-18","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amyvid","generic_name":"FLORBETAPIR F 18","company_name":"Avid Radiopharms Inc","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":48,"revenue":null,"mechanism":"Amyvid works by binding to amyloid beta A4 protein in the brain, allowing for visualization of amyloid plaques in Alzheimer's disease."},{"drug_id":"flortaucipir-f-18","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tauvid","generic_name":"FLORTAUCIPIR F 18","company_name":"Avid Radiopharms Inc","drug_phase":"marketed","molecular_target":"Microtubule-associated protein tau","drug_class":"","quality_score":45,"revenue":null,"mechanism":"Tauvid binds to tau protein in the brain, allowing for visualization of tau pathology through PET imaging."},{"drug_id":"gallium-68ga-gozetotide","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Locametz","generic_name":"Gallium (68Ga) gozetotide","company_name":"Univ Ca Los Angeles","drug_phase":"discontinued","molecular_target":"Glutamate carboxypeptidase 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Locametz works by binding to glutamate carboxypeptidase 2, a protein overexpressed in certain types of cancer, allowing for visualization of cancer cells through PET imaging."},{"drug_id":"fluciclovine-18f","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Axumin","generic_name":"fluciclovine (18F)","company_name":"Blue Earth Diagnostics Ltd","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":41,"revenue":null,"mechanism":"Axumin works by binding to specific sites in the body, emitting positrons that create images during PET scans."},{"drug_id":"florbetaben-f18","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neuraceq","generic_name":"FLORBETABEN F18","company_name":"Piramal Imaging","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"copper-dotatate-cu-64","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Detectnet","generic_name":"copper dotatate Cu-64","company_name":"Radiomedix","drug_phase":"marketed","molecular_target":"somatostatin receptors, particularly SSTR2","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":47,"revenue":null,"mechanism":"Copper Cu 64 dotatate binds to somatostatin receptors, particularly SSTR2, on neuroendocrine tumor cells, allowing PET imaging."},{"drug_id":"fluorodopa-18f","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fluorodopa F18","generic_name":"fluorodopa (18F)","company_name":"Feinstein","drug_phase":"marketed","molecular_target":"","drug_class":"fluorodopa (18F)","quality_score":31,"revenue":null,"mechanism":""},{"drug_id":"fluoroestradiol-f-18","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cerianna","generic_name":"FLUOROESTRADIOL F-18","company_name":"GE HealthCare","drug_phase":"marketed","molecular_target":"Estrogen receptor","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":50,"revenue":null,"mechanism":"Cerianna works by binding to estrogen receptors in the body, allowing for imaging of these receptors through positron emission tomography."},{"drug_id":"flutemetamol-18f","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vizamyl","generic_name":"Flutemetamol (18F)","company_name":"GE HealthCare","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":65,"revenue":null,"mechanism":"Vizamyl works by binding to amyloid beta A4 protein in the brain, allowing for visualization of amyloid deposits in PET imaging."},{"drug_id":"rubidium","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rubidium Bromatum","generic_name":"RUBIDIUM","company_name":"Jubilant","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":""},{"drug_id":"gallium","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gallium Oxydatum","generic_name":"GALLIUM","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Glutamate carboxypeptidase 2, Prostate-specific antigen","drug_class":"","quality_score":20,"revenue":null,"mechanism":""},{"drug_id":"gallium-ga-68-dotatate","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Gallium Ga 68-DOTATATE","company_name":"Mayo Clinic","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Gallium Ga 68-DOTATATE works by binding to specific targets in the body, allowing for diagnostic imaging."},{"drug_id":"rubidium-rb-82-chloride","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rubidium Chloride Rb 82","generic_name":"rubidium Rb-82 chloride","company_name":"Bracco","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"amyvid","indication_name":"Positron emission tomography","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Amyvid","company_name":"Invicro","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03180060","title":"Meta-Analysis of Stress Myocardial Perfusion Imaging","phase":"","overall_status":"COMPLETED","enrollment_count":23051,"lead_sponsor_name":"American British Cowdray Medical Center","has_results":false},{"nct_id":"NCT04416165","title":"Comparison of FDG and FAPI in Patients With Various Types of Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT06827678","title":"Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04831541","title":"68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT06690970","title":"Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT06725693","title":"Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT06690957","title":"Somatostatin Receptor PET/CT in SSTR-Related Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT03563482","title":"Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT04831034","title":"68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT06688071","title":"FAPI PET/CT in Various FAP-Related Disease Patients","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT04499365","title":"68Ga-FAPI PET/CT in Patients With Various Types of Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT05970913","title":"PET-CT Predicting Lymph Nodes Metastasis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":280,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06558357","title":"Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":210,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06017973","title":"The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03402425","title":"The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05004961","title":"The Performance of Multi-tracer Multimodality PET in Lymphoma","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06690736","title":"Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Tianjin Medical University","has_results":false},{"nct_id":"NCT01721473","title":"Brain Nicotine Receptor Density in Veteran Smokers","phase":"","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04478318","title":"Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06465017","title":"ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":149,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT04555642","title":"Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT03679936","title":"Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04525612","title":"68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT06696326","title":"A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT05610098","title":"Gene Expression Profiles in Spinal Tuberculosis.","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT06324890","title":"PET-CT Imaging Features of Meibomian Glands","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05188872","title":"Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT04605939","title":"Clinical Application of Fibroblast Activation Protein PET/MRI in Liver Fibrosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06188468","title":"ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT06148207","title":"[18F]BF3-BPA Injection for PET Imaging Study of Gliomas in the Brain","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT05140083","title":"68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT03741231","title":"18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05392205","title":"Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT06027021","title":"Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT06084767","title":"68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06203574","title":"Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT04001257","title":"18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04515368","title":"A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity","phase":"NA","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT03802123","title":"⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"ImaginAb, Inc.","has_results":true},{"nct_id":"NCT03830242","title":"Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Fifth Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04982458","title":"Visualized Monitoring of Fibrosis Formation in Heart Failure With 68GA-FAPI PET","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT04533828","title":"68Ga-FAPI PET/CT in Liver Fibrosis Patients","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT05506566","title":"68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT03324893","title":"FCH PET/MRI Parathyroid Localization","phase":"NA","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06919159","title":"Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Jiequn Yu","has_results":false},{"nct_id":"NCT05516719","title":"Longitudinal Investigation of I2BS in PD","phase":"","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT05516732","title":"Serotonin Release in Premotor and Motor PD","phase":"","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT06116188","title":"Brain Insulin Resistance in Mild Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Turku University Hospital","has_results":false},{"nct_id":"NCT06203587","title":"Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06203613","title":"Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"YiHui Guan","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}